Skip to content
Politically.com Search all
Menu

2026 · 2nd Quarter (Apr 1 - June 30)

UCB, INC.

Filed by UCB, INC..

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 18, 2026
Income
Not reported
Expenses
$710,000.00
Registrant
UCB, INC.
Client
UCB, INC.
Filing UUID
e148d0d3-b635-4978-a6e4-4d07af99d311
Termination date
Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

PHA · Pharmacy

H.R. 5509/S. 2903 - Safe Step Act H.R. 6423/S. 864 - HELP Copays Act H.R. 1189/S. 494 - National Plan for Epilepsy Act Drug Pricing

Literal federal measure citations: H.R. 5509, S. 2903, H.R. 6423, S. 864, H.R. 1189, S. 494

TRD · Trade (domestic/foreign)

Tariffs

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.